Avinger Inc.

Canaccord Genuity is pleased to announce that on February 4, 2015, it completed an underwritten initial public offering of common stock for Avinger Inc. (NASDAQ: AVGR).  The company issued a total of 5,000,000 shares of common stock at a price of $13.00 per share.  In addition, the underwriters have been granted a 30-day option to purchase up to an additional 750,000 common shares at the initial public offering price.  Canaccord Genuity acted as lead bookrunning manager for the offering.  Avinger intends to use the net proceeds from this offering for sales and marketing initiatives, research and development activities, and general corporate purposes.

Avinger is a commercial-stage medical device company that designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral arterial disease, or PAD.  The company manufactures and sells a suite of products including the Lightbox imaging console, as well as the Wildcat, Kittycat, and the Ocelot family of catheters.  Avinger is based in Redwood City, California.